| Pharmaceutical active ingredients: |
| Pipethanate |
| Available forms, composition and doses of Nospasmin: |
| Drops; Oral; Pipethanate 5 mg / ml |
| Nospasmin medical category: |
| Human:AntispasmodicsOrganophosphate and carbamate poisoning specific antidotes |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Instituto Sanitas |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
No-Spa Forte | Drotaverine Hydrochloride | Sanofi-Aventis; Chinoin Pharmaceutical and Chemical Works |
| Nospalgin | Acetaminophen; Codeine Phosphate; Drotaverine Hydrochloride | Sanofi-Aventis; Chinoin Pharmaceutical and Chemical Works |
| No-Spalgin | Acetaminophen; Codeine Phosphate; Drotaverine Hydrochloride | Sanofi-Aventis; Chinoin Pharmaceutical and Chemical Works |
| Nospan | Dextromethorphan Hydrobromide | Y.S.P. Industries |
| Nospasm | Carisoprodol | Unidentified Pharmaceutical Company |
| Nospasmin Compuesto | Metamizole Magnesium; Pipethanate Hydrochloride | Instituto Sanitas |
| Nospilin | Antazoline Sulfate; Xylometazoline Hydrochloride | Novartis |
| Nossacin | Cinoxacin | Benedetti |
| Nostaden | Cyclobenzaprine Hydrochloride | Mintlab |
| Nostel | Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride | Pyridam |